Glyceraldehyde-3-phosphate dehydrogenase pseudogene 76 (GAPDHP76)

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 76 (GAPDHP76) is a processed pseudogene related to the gene encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a key glycolytic enzyme. Pseudogenes like GAPDHP76 arise through duplication or retrotransposition events and typically accumulate disabling mutations that prevent them from producing functional proteins. According to the GeneCards database and supporting literature, GAPDHP76 does not encode a protein and is not known to have a physiological or pathological role. The GAPDH gene family includes many processed pseudogenes in mammals, reflecting high transcriptional activity and evolutionary duplication events[1][2]. Current knowledge does not attribute regulatory or disease-related functions to GAPDHP76 in particular. Summary: GAPDHP76 is a pseudogene, not a functional molecule or recognized therapeutic target. It is not suitable as a target for drug development, nor is it clinically relevant as a biomarker or disease gene[1][2].

Other names

GAPDH pseudogene 76